2021/10/15-
Stem cells as potential therapeutic approaches for inflammatory bowel disease
17:40-18:00
Guangdong Hall III
Clinical Forum I Cutting-edge forum on IBD therapies
Speaker
- 2021/10/16
-
(BA07) Olamkicept, a novel IL-6 trans-signaling Inhibitor, induces rapid clinical improvements in moderate to severe ulcerative colitis: phase 2 study results
(BA07) Olamkicept, a novel IL-6 trans-signaling Inhibitor, induces rapid clinical improvements in moderate to severe ulcerative colitis: phase 2 study results
09:00-09:15
Guangdong Hall I
Clinical Forum II Special timing of IBD: pediatrics, breastfeeding and elders
Speaker
PROGRAM
